WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device with Delivery System - Cardiac occluder
ARTG ID: 464147 · Boston Scientific Pty Ltd · Boston Scientific Corporation · Class I · Started October 11, 2024
Good Name: Boston Scientific Pty Ltd - WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device with Delivery System - Cardiac occluder
- Risk Class
- Class I
- Product Type
- Medical device system
- ARTG Category
- General-Export
- ARTG ID
- 464147
- Start Date
- October 11, 2024
- Effective Date
- October 11, 2024
- Country
- United States of America
- Address
- 300 Boston Scientific Way, Marlborough, MA, 01752
WATCHMAN FLX Pro is intended for percutaneous, transcatheter closure of the left atrial appendage.
Access comprehensive regulatory information for WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device with Delivery System - Cardiac occluder in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is registered under ARTG number 464147 and sponsored by Boston Scientific Pty Ltd, manufactured by Boston Scientific Corporation in United States of America. The device registration started on October 11, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.